These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17241877)

  • 1. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
    Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
    Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism.
    Lazarska KE; Dekker SJ; Vermeulen NPE; Commandeur JNM
    Toxicol Lett; 2018 Mar; 284():70-78. PubMed ID: 29203276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.
    Aithal GP; Ramsay L; Daly AK; Sonchit N; Leathart JB; Alexander G; Kenna JG; Caldwell J; Day CP
    Hepatology; 2004 May; 39(5):1430-40. PubMed ID: 15122773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis.
    Aithal GP; Day CP; Leathart JB; Daly AK
    Pharmacogenetics; 2000 Aug; 10(6):511-8. PubMed ID: 10975605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRP2 haplotypes confer differential susceptibility to toxic liver injury.
    Choi JH; Ahn BM; Yi J; Lee JH; Lee JH; Nam SW; Chon CY; Han KH; Ahn SH; Jang IJ; Cho JY; Suh Y; Cho MO; Lee JE; Kim KH; Lee MG
    Pharmacogenet Genomics; 2007 Jun; 17(6):403-15. PubMed ID: 17502832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
    Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
    Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity.
    Agúndez JA; Lucena MI; Martínez C; Andrade RJ; Blanca M; Ayuso P; García-Martín E
    Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):817-28. PubMed ID: 21473713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
    Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
    PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.
    Aithal GP; Day CP
    Clin Liver Dis; 2007 Aug; 11(3):563-75, vi-vii. PubMed ID: 17723920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.
    Ma CL; Wu XY; Jiao Z; Hong Z; Wu ZY; Zhong MK
    Pharmacogenomics; 2015; 16(4):347-60. PubMed ID: 25823783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methotrexate in pediatric acute lymphoblastic leukemia: impact of ABCC2 polymorphisms on plasma concentrations.
    Rau T; Erney B; Göres R; Eschenhagen T; Beck J; Langer T
    Clin Pharmacol Ther; 2006 Nov; 80(5):468-76. PubMed ID: 17112803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein.
    de Jong FA; Scott-Horton TJ; Kroetz DL; McLeod HL; Friberg LE; Mathijssen RH; Verweij J; Marsh S; Sparreboom A
    Clin Pharmacol Ther; 2007 Jan; 81(1):42-9. PubMed ID: 17185998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity.
    Aithal GP
    Expert Opin Drug Saf; 2004 Nov; 3(6):519-23. PubMed ID: 15500411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR2 and CCR5 promote diclofenac-induced hepatotoxicity in mice.
    He Z; Wei G; Li N; Niu M; Gong S; Wu G; Wang T; Jiang Y; Chen P
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Mar; 392(3):287-297. PubMed ID: 30483860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity.
    Krasniqi V; Dimovski A; Domjanović IK; Bilić I; Božina N
    Arh Hig Rada Toksikol; 2016 Mar; 67(1):1-8. PubMed ID: 27092633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
    Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
    Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of UGT1A8, UGT1A9, UGT2B7 and ABCC2 in Chinese renal transplant recipients and a comparison with other ethnic populations.
    Deng XY; Wang CX; Wang XD; Bi HC; Chen X; Li JL; Huang M
    Pharmazie; 2013 Apr; 68(4):240-4. PubMed ID: 23700788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
    Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
    J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.